In this study, we showed that RNF19A not only decreased p53 expression at the protein level but also regulated the downstream signalling of p53, suggesting that RNF19A might promote NSCLC development by decreasing p53 function. The gene discussed is TP53; the disease is non-small cell lung carcinoma.